United Kingdom · 
Who invested in Perfectus Biomed?
Perfectus Biomed's investors include North West Fund, North West Fund for Biomedical and midVentures.
20142015
$152KSeed$305KSeedUnited Kingdom · Seed startup
Who invested in Perfectus Biomed
Funding summaryUpdated 26 Oct 2026
$456Kraised across 2 rounds since 2013, from 2 sources
$152KSeed$305KSeed
- Latest round
- Seed, $305KApr 2015
- Step-upi
- 2×
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Seed, $152K Jun 2013
- Biggest round
- $305K Seed · Apr 2015
- Between rounds
- 22 months from the last two
The rounds
- Apr 2015
- Jun 2013
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
North West Fund for BiomedicalInvestment firm1round
midVenturesno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Perfectus Biomed as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Perfectus Biomed
How much has Perfectus Biomed raised?
Perfectus Biomed has raised $456K across 2 rounds since 2013.
When did Perfectus Biomed last raise?
Perfectus Biomed's most recent round was a Seed of $305K in Apr 2015.
What was Perfectus Biomed's biggest round?
Its most recent round, $305K in Apr 2015, is also its largest on record.
Who backed Perfectus Biomed first?
Perfectus Biomed's first round on record, in Jun 2013, was backed by North West Fund, North West Fund for Biomedical and midVentures.
What stage is Perfectus Biomed at?
Perfectus Biomed's latest named round is a Seed, in Apr 2015.
Where is Perfectus Biomed based?
Perfectus Biomed is based in the United Kingdom.
Companies like Perfectus Biomed
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.